We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Oral Contraceptives Impact Quality of Life

By HospiMedica International staff writers
Posted on 03 May 2017
Print article
A new study demonstrates a statistically significant reduction in general wellbeing of women using oral contraceptives.

Researchers at Karolinska Institutet, Karolinska University Hospital, and other institutions conducted a double-blind, placebo-controlled trial involving 340 healthy women (18-35 years of age) who were randomized to a combined oral contraceptive (150 μg levonorgestrel and 30 μg ethinylestradiol) or placebo for three months of treatment. Primary outcome measures included global score of the Psychological General Well-Being Index (PGWBI) and the Beck Depression Inventory (BDI).

In all, 332 women completed data collection at follow-up evaluation. The results showed that the oral contraceptive treatment significantly decreased general wellbeing, compared with placebo. In addition, several PGWBI dimensions were decreased compared with placebo, including positive wellbeing, self-control, and vitality. The effect of oral contraceptives on depressive symptoms and on the PGWBI “depressed mood” dimension were not statistically significant. The study was published on April 19, 2017, in Fertility and Sterility.

“Despite the fact that an estimated 100 million women around the world use contraceptive pills, we know surprisingly little today about the pill’s effect on women’s health,” said lead author Professor Angelica Lindén Hirschberg, MD, of Karolinska Institutet. “The scientific base is very limited as regards the contraceptive pill’s effect on quality of life and depression, and there is a great need for randomized studies where it is compared with placebos.”

The combined oral contraceptive pill, colloquially known as "the pill", is a birth control method that includes a combination of an estrogen and a progestogen. When taken per-os daily, these pills inhibit female fertility (with reversibility). Pills containing ethinylestradiol and levonorgestrel are the first choice of combined oral contraceptives in Sweden and many other countries, as they are considered to entail the least risk of thrombosis among all combined contraceptive pills.

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
X-Ray Detector
FDR-D-EVO III

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.